Hangzhou AGS MedTech Co., Ltd. (SHA:688581)
59.07
-1.92 (-3.15%)
At close: May 21, 2026
Hangzhou AGS MedTech Revenue
Hangzhou AGS MedTech had revenue of 140.44M CNY in the quarter ending March 31, 2026, with 9.21% growth. This brings the company's revenue in the last twelve months to 609.05M, down -6.83% year-over-year. In the year 2025, Hangzhou AGS MedTech had annual revenue of 593.74M, down -6.74%.
Revenue (ttm)
609.05M
Revenue Growth
-6.83%
P/S Ratio
7.83
Revenue / Employee
818.61K
Employees
856
Market Cap
4.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 593.74M | -42.89M | -6.74% |
| Dec 31, 2024 | 636.63M | 127.89M | 25.14% |
| Dec 31, 2023 | 508.75M | 137.64M | 37.09% |
| Dec 31, 2022 | 371.11M | 65.65M | 21.49% |
| Dec 31, 2021 | 305.47M | 133.51M | 77.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| GKHT Medical Technology | 6.82B |
| Guangdong Biolight Meditech | 1.10B |
| Shenzhen Lifotronic Technology | 1.08B |
| Getein Biotech | 1.08B |
| Zhejiang Orient Gene Biotech | 1.01B |
| Shanghai Kinetic Medical | 869.21M |
| Shanghai Aohua Photoelectricity Endoscope | 787.64M |
| Nanjing Vishee Medical Technology | 472.85M |